It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Justin J. McAnear net worth and biography

Justin McAnear Biography and Net Worth

CFO of 10x Genomics

Justin McAnear has served as Chief Financial Officer of 10x Genomics since 2018, bringing over 20 years of financial and operational leadership experience in dynamic, high-growth environments. Prior to joining 10x, Justin was the Vice President of Worldwide Finance and Operations at Tesla, where he helped scale the company through the Model X and Model 3 launches. Justin also served as a Finance Director at Apple in Corporate FP&A and Worldwide Operations. Justin began his career at Johnson & Johnson where he held various roles. Justin served over nine years in the U.S. Navy as an aviator, and is a graduate of the U.S. Naval Academy in Annapolis, MD, where he earned his B.S. degree in Systems Engineering. He also holds a M.B.A. in Finance from the University of San Diego.

What is Justin J. McAnear's net worth?: The estimated net worth of Justin J. McAnear is at least $1.88 million as of August 22nd, 2024. Mr. McAnear owns 143,242 shares of 10x Genomics stock worth more than $1,880,767 as of November 21st. This net worth approximation does not reflect any other investments that Mr. McAnear may own. Learn More about Justin J. McAnear's net worth.
How do I contact Justin J. McAnear?: The corporate mailing address for Mr. McAnear and other 10x Genomics executives is 6230 STONERIDGE MALL ROAD, PLEASANTON CA, 94588. 10x Genomics can also be reached via phone at 925-401-7300 and via email at [email protected]. Learn More on Justin J. McAnear's contact information.
Has Justin J. McAnear been buying or selling shares of 10x Genomics?: Justin J. McAnear has not been actively trading shares of 10x Genomics during the last ninety days. Learn More on Justin J. McAnear's trading history.
Who are 10x Genomics' active insiders?: 10x Genomics' insider roster includes Bradford Crutchfield (Insider), Benjamin Hindson (Insider), Sridhar Kosaraju (Director), Mathai Mammen (Director), Justin McAnear (CFO), Serge Saxonov (CEO), John Stuelpnagel (Director), and James Wilbur (Insider). Learn More on 10x Genomics' active insiders.
Are insiders buying or selling shares of 10x Genomics?: During the last year, insiders at the sold shares 17 times. They sold a total of 57,543 shares worth more than $2,038,285.55. The most recent insider tranaction occured on August, 22nd when CEO Serge Saxonov sold 6,749 shares worth more than $152,054.97. Insiders at 10x Genomics own 10.0% of the company. Learn More about insider trades at 10x Genomics.
Information on this page was last updated on 8/22/2024.

Justin J. McAnear Insider Trading History at 10x Genomics

Justin J. McAnear Buying and Selling Activity at 10x Genomics

10x Genomics Company Overview

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Today's Range

Now: $13.13

$13.06

$13.27

50 Day Range

MA: $17.91

$13.18

$23.48

2 Week Range

Now: $13.13

$12.95

$57.90

Volume

67,105 shs

Average Volume

1,720,866 shs

Market Capitalization

$1.59 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.87

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share

From Darwin | Ad

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]